businessinsider.com
These are Insider’s biggest healthcare stories for the week ending April 2.
almost 3 years ago
bizjournals.com
Rowan Walrath joins Business Journal, covering life sciences - Boston Business Journal Boston Business Journal
almost 3 years ago
bizjournals.com
Second-mover advantage: Beyond Moderna, Boston-area firms like CureVac, Translate Bio, Greenlight and Mass. Eye and Ear are still developing Covid vaccines - Boston Business Journal Boston Business Journal
about 3 years ago
bizjournals.com
Medtech VC BioVentures raising $350M fund - Boston Business Journal Boston Business Journal
about 3 years ago
bizjournals.com
Biogen, messenger RNA and CRISPR creators: These were the top five stories in Boston biotech - Boston Business Journal Boston Business Journal
about 3 years ago
bizjournals.com
After supporting Beth Israel, Aldatu Biosciences launching Covid diagnostic testing business - Boston Business Journal Boston Business Journal
about 3 years ago
bizjournals.com
Celtics' Wyc Grousbeck, partners launch SPAC - Boston Business Journal Boston Business Journal
about 3 years ago
Search by beat, location, outlet & position to find the right journalists for your story.
Sign up for freebizjournals.com
Omega Funds plans life sciences SPAC - Boston Business Journal Boston Business Journal
about 3 years ago
politico.com
DELEO'S domino effect – VELIS opens up about ALCOHOLISM – BROOKLINE rocked by SCHOOL REOPENING Politico
about 3 years ago
bizjournals.com
Biotech Agios sells cancer portfolio for $2 billion to Serveir - Boston Business Journal Boston Business Journal
about 3 years ago
bizjournals.com
Top former Alnylam exec Barry Greene named CEO of Sage Therapeutics - Boston Business Journal Boston Business Journal
about 3 years ago
bizjournals.com
Three takeaways from the FDA's initial review of Moderna's Covid-19 vaccine - Boston Business Journal Boston Business Journal
about 3 years ago
bizjournals.com
How SPAC mergers became popular in 2020 - Boston Business Journal Boston Business Journal
about 3 years ago
bizjournals.com
Head of Mass. biotech industry group MassBio to step down - Boston Business Journal Boston Business Journal
about 3 years ago
bizjournals.com
Biogen, FDA's Alzheimer's disease collaboration draws criticism - Boston Business Journal Boston Business Journal
about 3 years ago
bizjournals.com
Women Who Mean Business: Reshma Kewalramani - Boston Business Journal Boston Business Journal
about 3 years ago
bizjournals.com
Neurodegeneration biotech Vigil licenses Amgen Alzheimer's drugs - Boston Business Journal Boston Business Journal
about 3 years ago
bizjournals.com
Biotech Remix plans RNA therapies for cancer, rare diseases Boston Business Journal
about 3 years ago
bizjournals.com
Moderna reaffirms 20M vaccine dose goal for December - Boston Business Journal Boston Business Journal
about 3 years ago
bizjournals.com
With profits down, Boston Scientific sells product line for $800M - Boston Business Journal Boston Business Journal
about 3 years ago
bizjournals.com
Vertex buys back $500M in stock, cell therapy startup raises $42M - Boston Business Journal Boston Business Journal
about 3 years ago
